Filing Details
- Accession Number:
- 0001237899-14-000068
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-10 16:00:35
- Reporting Period:
- 2014-09-08
- Filing Date:
- 2014-09-10
- Accepted Time:
- 2014-09-10 16:00:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1013064 | Roy P Vagelos | 777 Old Saw Mill River Road Tarrytown NY 10591 | Chairman Of The Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-09-05 | 1 | $0.00 | 0 | No | 5 | G | Indirect | by GRAT |
Common Stock | Disposition | 2014-09-05 | 3 | $0.00 | 0 | No | 5 | G | Indirect | by GRAT |
Common Stock | Disposition | 2014-09-08 | 2 | $351.00 | 103,273 | No | 4 | S | Indirect | by Spouse as Trustee |
Common Stock | Disposition | 2014-09-10 | 10,326 | $350.07 | 92,947 | No | 4 | S | Indirect | by Spouse as Trustee |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Indirect | by GRAT |
No | 5 | G | Indirect | by GRAT |
No | 4 | S | Indirect | by Spouse as Trustee |
No | 4 | S | Indirect | by Spouse as Trustee |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 390,852 | Direct | |
Common Stock | 2,270 | Indirect | By 401(k) Plan |
Common Stock | 156,368 | Indirect | by CLAT |
Common Stock | 10,961 | Indirect | by GRAT |
Common Stock | 1,203 | Indirect | by trust for grandch |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 10,326 shares of Company stock on September 10, 2014 at prices ranging from $350.00 to $350.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 10, 2014 at each separate price.
- By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.